Search

everythinglearnresearchcommunity

for

Search:↓

Both baricitinib and tofacitinib effectively reduce alopecia areata severity, with tofacitinib showing more improvement over longer use.

The combination of vitamin D analogues with potent steroids is a favorable treatment for alopecia areata with fewer side effects.

JAK1 inhibitor may effectively treat alopecia areata when TNF-α inhibitors and corticosteroids fail.

Belimumab may cause hair loss in lupus patients.

Baricitinib effectively improved skin and hair conditions in a patient with alopecia areata and atopic dermatitis.

Baricitinib was effective in treating hair loss in adults with alopecia areata according to patient feedback.

Upadacitinib effectively treated severe atopic dermatitis, vitiligo, and alopecia areata in one patient.

Baricitinib effectively treated alopecia areata in 73% of patients, with minor metabolic changes and significant changes in inflammatory markers.

The new clobetasol propionate foam is effective and safe for treating alopecia areata.

Upadacitinib significantly improved alopecia universalis and psoriatic arthritis in a patient.

Baricitinib was effective and safe for severe hair loss treatment over 6 months.

Rezpegaldesleukin shows promise for treating severe alopecia areata.

JAK inhibitors and combination therapies show promise for treating severe alopecia areata.

Alefacept showed some effectiveness for alopecia areata but needs more research.

Upadacitinib effectively treats psoriasiform eczema and some related conditions.

Low-dose tofacitinib is effective and cheaper for severe alopecia areata.

Baricitinib effectively promotes hair regrowth and improves well-being in severe alopecia areata patients.

Baricitinib effectively reduces hair loss in severe alopecia areata with mild side effects.

Baricitinib helps grow eyebrows and eyelashes in severe alopecia areata patients.

Tofacitinib and baricitinib are similarly effective and safe for alopecia areata, but baricitinib works faster.

Abrocitinib helped a 14-year-old girl with severe alopecia areata regrow her hair significantly.

Tofacitinib shows promise for treating severe hair loss in adults and teens, with many experiencing regrowth, but hair loss returns when treatment stops.

Baricitinib is a promising treatment for alopecia areata.

Baricitinib is a relatively safe and effective treatment for severe alopecia areata.

Baricitinib effectively treats both rheumatoid arthritis and alopecia areata.

Mesalazine may help treat extensive alopecia areata effectively.

Tofacitinib and baricitinib are effective and safe for treating severe alopecia areata, especially in younger people.

Baricitinib is effective and safe for treating severe alopecia areata with ongoing use.

Mycophenolate mofetil helped reduce steroid use in treating a dog's autoimmune skin disease.

Sacituzumab tirumotecan shows promise in treating breast cancer with manageable side effects.